These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36423044)

  • 1. Insight into Prevention of Neisseria Gonorrhoeae: A Short Review.
    La Fauci V; Lo Giudice D; Squeri R; Genovese C
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423044
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.
    Thng C; Semchenko EA; Hughes I; O'Sullivan M; Seib KL
    BMC Public Health; 2023 Mar; 23(1):607. PubMed ID: 36997957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
    Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
    Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against
    Seib KL; Donovan B; Thng C; Lewis DA; McNulty A; Fairley CK; Yeung B; Jin F; Fraser D; Bavinton BR; Law M; Chen MY; Chow EPF; Whiley DM; Mackie B; Jennings MP; Jennison AV; Lahra MM; Grulich AE
    BMJ Open; 2024 Apr; 14(4):e081675. PubMed ID: 38626958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
    Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
    PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
    Semchenko EA; Tan A; Borrow R; Seib KL
    Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect.
    Ruiz García Y; Sohn WY; Seib KL; Taha MK; Vázquez JA; de Lemos APS; Vadivelu K; Pizza M; Rappuoli R; Bekkat-Berkani R
    NPJ Vaccines; 2021 Oct; 6(1):130. PubMed ID: 34716336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol.
    Marshall H; Ward J; Wang B; Andraweera P; McMillan M; Flood L; Bell C; Sisnowski J; Krause V; Webby R; Childs E; Gunathilake M; Egoroff N; Leong L; Lawrence A; Baird R; Freeman K; Menouhos D; Whiley DM; Karnon J; van Hal S; Lahra MM
    BMJ Open; 2024 May; 14(5):e079144. PubMed ID: 38719318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
    Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
    BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: results from a decision-analysis model.
    Régnier SA; Huels J
    Hum Vaccin Immunother; 2014; 10(12):3737-45. PubMed ID: 25483706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating vaccine-elicited antibody activities against
    Gray MC; Thomas KS; Lamb ER; Werner LM; Connolly KL; Jerse AE; Criss AK
    Infect Immun; 2023 Dec; 91(12):e0030923. PubMed ID: 37991382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis.
    Wang B; Mohammed H; Andraweera P; McMillan M; Marshall H
    J Infect; 2024 Sep; 89(3):106225. PubMed ID: 38986746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential utility of liposomes for
    Christodoulides M; Humbert MV; Heckels JE
    Expert Rev Vaccines; 2021 Oct; 20(10):1235-1256. PubMed ID: 34524062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal B vaccine (4CMenB): the journey from research to real world experience.
    Rappuoli R; Pizza M; Masignani V; Vadivelu K
    Expert Rev Vaccines; 2018 Dec; 17(12):1111-1121. PubMed ID: 30457407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploitation of
    Petousis-Harris H; Radcliff FJ
    Front Immunol; 2019; 10():683. PubMed ID: 31024540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 18. A meningococcal B vaccine induces cross-protection against gonorrhea.
    Azze RFO
    Clin Exp Vaccine Res; 2019 Jul; 8(2):110-115. PubMed ID: 31406692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.
    Bettencourt C; Nogueira P; Paulo Gomes J; João Simões M
    Vaccine; 2022 Aug; 40(33):4772-4779. PubMed ID: 35778280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.